Abstract
The role of calcitonin and parathyroid hormone (PTH) in corticosteroid-induced osteoporosis is controversial. We therefore measured plasma calcitonin and PTH levels in 34 adults receiving chronic pharmacological corticosteroids for obstructive airways disease, and in controls matched for age, sex, menopause, and disease. In addition, the acute effect of a 7-day course of 15 mg prednisolone daily on fasting and calcium-stimulated calcitonin was studied in 10 normal male volunteers. There was no difference in calcitonin and PTH levels in the corticosteroid-treated patients when compared with controls. The corrected serum calcium was significantly higher in the steroid-treated patients (patients mean 2.40 (SEM 0.01) mmol/liter; controls mean 2.33 (SEM 0.01) mmol/liter; P<0.001). The short course of corticosteroids in volunteers did not alter basal or stimulated calcitonin, PTH, or calcium levels. These results suggest that neither calcitonin deficiency nor PTH excess is a feature of corticosteroid-induced osteoporosis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309:265–268
Ruegsegger P, Medici TC, Anliker M (1983) Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with biochemical asthma using quantitative computed tomography. Eur J Clin Pharmacol 25:615–620
Reid IR (1989) Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 30:83–103
Meunier PJ, Dempster DW, Edouard C, Chapuy MC, Arlot M, Charhon S (1984) Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome. Adv Exp Med Biol 171:191–200
Reid IR, Chapman GE, Fraser TRC, Davies AD, Suras AS, Meyer J, Huq NL, Ibbertson HK (1986) Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab 62:379–383
Reid IR, Katz J, Ibbertson HK, Gray WJ (1986) The effects of hydrocortisone, parathyroid hormone and the bisphosphonate APD on bone resorption in neonatal mouse calvaria. Calcif Tissue Int 38:38–43
Fucik RF, Kukreja SC, Hargis GK, Bowser EN Henderson WJ, Williams GA (1975) Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab 40:152–155
Chambers TJ, Moore A (1983) The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. J Clin Endocrinol Metab 57:819
Lo Cascio V, Adami S, Avioli LV, Cominacini L, Galvanni G, Gennari C (1982) Suppressive effect of chronic glucocorticoid treatment on circulating calcitonin in man. Calcif Tissue Int 34:309–310
Gennari C, Civitelli R (1986) Glucocorticoid-induced osteoporosis. Clin Rheum Dis 12:637–654
Toring O, Bucht E, Thorer M, Sjoberg HE (1986) Plasma calcitonin response to a calcium clamp in endogenous Cushing's syndrome. Acta Endocrinol 111:258–263
Wright AD, Joplin GF (1969) Skin-fold thickness in normal subjects and in patients with acromegaly and Cushing's syndrome. Acta Endocrinol 60:705–711
Lynch C, Seth R, Bates DL, Self CH (1988) Calcitonin determination by a fast and highly sensitive enzyme-amplified immunoassay. J Immunoassay 9:179–192
Riancho JA, Gonzales-Macias J, Del Arco C, Amado JA, Freijanes J, Anton MA (1987) Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. Thorax 42:962–966
Bernard P, Jonsset V, Gorel JM (1989) Calcitonin gene expression in adrenalectomised rats: effects of dexamethasone and calcium. J Bone Miner Res Joint Meeting ASB and ICCRH, abstract 115
Cote JC, Gagel RF (1986) Dexamethasone differentially affects the levels of calcitonin and calcitonin gene-related peptide mRNA expressed in human medullary thyroid carcinoma cell line. J Biol Chem 261:15524–15528
Riggs BL, Melton LJ III (1986) Involutional osteoporosis. New Engl J Med 314:1676–1686
Tiegs RD, Body JJ, Barta JM, Health H III (1986) Secretion and metabolism of monomeric human calcitonin: effects of age, sex and thyroid damage. J Bone Miner Res 1:339–349
Prince RL, Dick IM, Price RI (1989) Plasma calcitonin levels are not lower than normal in osteoporotic women. J Clin Endocrinol Metab 68:684–687
Parfitt AM (1979) Quantum concept of bone remodelling and turnover: implications for the pathogenesis of osteoporosis. Calcif Tissue Int 28:1–5
Overguard K, Riss BJ, Christiansen C, Podenphant J, Johansen JS (1986) Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol 30:435–442
Rizzato G, Tosi G, Schiraldi G, Montemurro L, Zanni D, Sisti S (1988) Bone protection with salmon calcitonin in the long-term steroid therapy of chronic sarcoidosis. Sarcoidosis 5:99–103
Luengo M, Picado C, Del Rio L, Guanabens N Montserrat JM, Setoain J (1990) Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study. Am Rev Respr Dis 142:104–107
Lukert BP, Adams JS (1976) Calcium and phosphorus homeostasis in man: the effect of corticosteroids. Arch Int Med 136: 1249–1253
Suzuki Y, Ichikawa Y, Saito, E, Homma M (1983) Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32:151–156
Gennari C, Imbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV (1984) Effects of prednisolone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int 36:245–252
Seeman E, Kumar R, Hunder GG, Scott M, Heath H, Riggs BL (1980) Production, degradation and circulating levels of 1,25-dihydroxy vitamin D in health and in chronic glucocorticoid excess. J Clin Invest 66:664–669
Slovik DM, Neer RM, Ohman JL, Lowell FC, Clark MB, Segre GV, Potts JT Jr (1980) Parathyroid hormone and 25-hydroxy vitamin D levels in glucocorticoid-treated patients. Clin Endocrinol 12:243–248
Hahn TJ, Halstead LR, Bran DT (1981) Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 52:111–115
Prummell MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HP (1991) The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 72:382–386
Need AG, Hartley TF, Philcox JC Nordin BEC (1986) Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women. Aust NZ J Med 16:341–346
Packe GE, Douglas JG, McDonald AF, Robins SP, Reid DM (1992) Bone density in asthmatic patients taking high-dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 47:414–417
Teitelbaum SL, Malone JD, Kahn AJ (1981) Glucocorticoid enhancement of bone resorption by rat peritoneal macrophages in vitro. Endocrinology 108:795–799
Rodan SB, Fischer MK, Egan JJ, Epstein PM, Rodan GA (1984) The effect of dexamethazone on parathyroid hormone stimulation of adenylate cyclase in ROS 17/28 cells. Endocrinology 115:951–958
Zajac JD, Livesey SA, Michelangeli VP, Rodan GA, Martin TJ (1986) Glucocorticoid treatment facilitates cyclic adenosine 3, ′5′-monosulphate-dependent protein kinase response in parathyroid hormone-responsive osteogenic sarcoma cells. Endocrinology 118:2059–2064
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hattersley, A.T., Meeran, K., Burrin, J. et al. The effect of long-and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels. Calcif Tissue Int 54, 198–202 (1994). https://doi.org/10.1007/BF00301678
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00301678